G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of G1 Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. G1 Therapeutics Inc market cap is $377.22M.
What is the 52-week high for G1 Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. G1 Therapeutics Inc 52 week high is $7.19 as of September 28, 2025.
What is the 52-week low for G1 Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. G1 Therapeutics Inc 52 week low is $1.08 as of September 28, 2025.
What is G1 Therapeutics Inc stock price today?
G1 Therapeutics Inc stock price today is $7.16.
What was G1 Therapeutics Inc stock price yesterday?
G1 Therapeutics Inc stock price yesterday was $7.15.
What is the PE ratio of G1 Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. G1 Therapeutics Inc’s P/E ratio is -8.30.
What is the Price-to-Book ratio of G1 Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. G1 Therapeutics Inc P/B ratio is 15.3216.
What is the 50-day moving average of G1 Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. G1 Therapeutics Inc 50-day moving average is $6.29.
